News

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Humana Inc. can proceed with a lawsuit alleging two Texas medical equipment suppliers owe it about $2.8 million after filing ...
The healthcare stock at just under $282 per share and had been as much as 17% higher at the open, but till held onto most of ...
Mizuho raised the firm’s price target on Humana (HUM) to $316 from $305 and keeps an Outperform rating on the shares. The firm surveyed 215 ...
Apple stock rises after a three-day stretch that has seen shares of the iPhone maker tumble 19%, Broadcom announces a new ...
Chip stocks rallied midday Tuesday, with Broadcom (AVGO) getting a particular boost after it authorized a $ ...
Guggenheim analyst Jason Cassorla initiated coverage of Humana (HUM) with a Buy rating and $326 price target The firm launched coverage on 11 ...
The 2024 Impact Report showcases Humana's impacts on communities, the dedication of employees and leaders, and how Humana is improving health outcomes through innovation and integrated care. The ...
The Centers for Medicare & Medicaid Services projects a 5.06% increase in payments, driven by new data on fee-for-service expenditures and enrollment trends.
Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.